Search research articles
Contact Us
Filters
Showing results (141-150 of 169) with videos related to
Page
of 17
Sort By:
The Journal of Clinical Investigation
|
December 1, 1981
Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa
K M Braunstein, C M Noyes, M J Griffith, et al.
Archives of Oral Biology
|
January 1, 1988
The assay of glandular kallikrein and prekallikrein in human mixed saliva
J W Jenzano, J C Coffey, W D Heizer, et al.
Biochemistry
|
September 25, 1984
Interaction of substrates with glutamine synthetase after limited proteolysis
D M Monroe, C M Noyes, R L Lundblad, et al.
Thrombosis Research
|
August 25, 1992
Affinity chromatography of platelets on immobilized thrombin: retention of catalytic activity by platelet-bound thrombin
H F Wu, G C White, E F Workman, et al.
Clinics in Haematology
|
June 1, 1985
Structure and function of factor IX: defects in haemophilia B
R A McGraw, L M Davis, R L Lundblad, et al.
The Journal of Biological Chemistry
|
March 15, 1988
The reaction of bovine alpha-thrombin with tetranitromethane. Characterization of the modified protein
R L Lundblad, C M Noyes, G L Featherstone, et al.
Analytical Biochemistry
|
December 1, 1986
Comparison of five techniques for the determination of protein content in mixed human saliva
J W Jenzano, S L Hogan, C M Noyes, et al.
Archives of Biochemistry and Biophysics
|
December 1, 1981
Biological activity and conformational stability of the domains of plasma fibronectin
D G Wallace, J W Donovan, P M Schneider, et al.
Acta Physiologica Scandinavica
|
November 1, 1992
Effects of acute and long-term atropine treatment on levels, release and response to VIP and PHI in the submandibular gland of cat and rat
M Dunér-Engström, O Larsson, B B Fredholm, et al.
Bibliotheca Cardiologica
|
January 1, 1984
Neuropeptides with vascular activity: VIP, PHI, NPY and substance P
J M Lundberg, T Hökfelt, A Anggård, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 169) with videos related to
Sort By:
Page
of 17
The Journal of Clinical Investigation
|
December 1, 1981
Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa
K M Braunstein, C M Noyes, M J Griffith, et al.
Archives of Oral Biology
|
January 1, 1988
The assay of glandular kallikrein and prekallikrein in human mixed saliva
J W Jenzano, J C Coffey, W D Heizer, et al.
Biochemistry
|
September 25, 1984
Interaction of substrates with glutamine synthetase after limited proteolysis
D M Monroe, C M Noyes, R L Lundblad, et al.
Thrombosis Research
|
August 25, 1992
Affinity chromatography of platelets on immobilized thrombin: retention of catalytic activity by platelet-bound thrombin
H F Wu, G C White, E F Workman, et al.
Clinics in Haematology
|
June 1, 1985
Structure and function of factor IX: defects in haemophilia B
R A McGraw, L M Davis, R L Lundblad, et al.
The Journal of Biological Chemistry
|
March 15, 1988
The reaction of bovine alpha-thrombin with tetranitromethane. Characterization of the modified protein
R L Lundblad, C M Noyes, G L Featherstone, et al.
Analytical Biochemistry
|
December 1, 1986
Comparison of five techniques for the determination of protein content in mixed human saliva
J W Jenzano, S L Hogan, C M Noyes, et al.
Archives of Biochemistry and Biophysics
|
December 1, 1981
Biological activity and conformational stability of the domains of plasma fibronectin
D G Wallace, J W Donovan, P M Schneider, et al.
Acta Physiologica Scandinavica
|
November 1, 1992
Effects of acute and long-term atropine treatment on levels, release and response to VIP and PHI in the submandibular gland of cat and rat
M Dunér-Engström, O Larsson, B B Fredholm, et al.
Bibliotheca Cardiologica
|
January 1, 1984
Neuropeptides with vascular activity: VIP, PHI, NPY and substance P
J M Lundberg, T Hökfelt, A Anggård, et al.
Page
of 17